Modern Radiotherapy for Pediatric Brain Tumors

Area of Science:

• Pediatric Oncology
• Radiation Oncology
• Neuro-oncology

Background:

• Central nervous system tumors are the most common solid malignancies in children and a leading cause of death.
• Radiotherapy (RT) is crucial for pediatric brain tumor management, significantly improving survival rates.
• However, RT in developing children poses risks of functional deficits, cosmetic defects, and secondary tumors.

Purpose of the Study:

• To review common radiotherapy modalities for pediatric brain tumors, including intensity modulated radiation therapy and proton therapy.
• To discuss the RT planning process, survival outcomes, and associated toxicities.
• To highlight strategies for mitigating acute and late treatment effects.

Main Methods:

• Review of current radiotherapy techniques: intensity modulated radiation therapy (IMRT) and proton therapy.
• Analysis of RT planning processes focusing on target volume conformity.
• Examination of dose limits for critical structures across different RT modalities.

Main Results:

• Advanced RT techniques improve dose conformity, reducing radiation exposure to healthy tissues.
• Treatment outcomes vary based on tumor histology, RT dose, and irradiated volume.
• Late effects, including neurocognitive deficits and endocrine dysfunction, are correlated with RT dose and volume, and inversely with patient age.

Conclusions:

• Volumetric planning and advanced RT modalities like IMRT and proton therapy are essential for minimizing late effects in pediatric brain tumor patients.
• Understanding and respecting dose constraints for critical structures is key to optimizing treatment safety.
• Continued research into RT techniques and mitigation strategies is vital for improving long-term quality of life for pediatric cancer survivors.